Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

News · April 12, 2024

ACC 2024: Sodium-Glucose Cotransporter 2 Inhibitors Safe, Effective in Adults With Congenital Heart Disease

Hospitalization rate for heart failure decreased significantly in the six months after SGLT2i initiation versus six months before

PracticeUpdate Editorial Team


Further Reading